Drug recall · January 14, 2015
Gabapentin Capsules recall
Why: Failed Tablet/Capsule Specifications: Complaints of empty capsules received.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.
- Lots / codes
Lot #: GESB14011-A, Exp 12/15
- Quantity
- 24,816 bottles
- Company
- Aurobindo Pharma USA Inc, Dayton, NJ
- Distribution
- Nationwide
- Initiated
- October 17, 2014 · Voluntary: Firm initiated
- Classified
- January 6, 2015
- Reported
- January 14, 2015
- Ended
- May 23, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gabapentin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.